(Q77526036)

English

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

scientific article published on 01 January 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

influenza vaccine

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

Jacqueline M. Katz

3

object named as

Jacqueline M Katz

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Xiuhua Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

J D Clements

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

7-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1019-1029

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the mucosal immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced Infectivity of Cold-Adapted Influenza A H1N1 Viruses in the Elderly: Correlation with Serum and Local Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization against influenza in humans using an oral enteric-coated killed virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-dependent antibody response in mice and humans following oral influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation using bacterial enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between a low toxicity of the mutant A subunit of enterotoxigenic Escherichia coli enterotoxin and its strong adjuvant action.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically derived toxoids for use as vaccines and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral immunization with influenza virus in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses and protection in mice immunized orally against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thein vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin adjuvant greatly promotes antigen priming of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900452-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00452-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11803061%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77526036&oldid=1784362033"